J Korean Med Sci.  2017 Apr;32(4):576-580. 10.3346/jkms.2017.32.4.576.

The Prevalence of Marfan Syndrome in Korea

• Jang SY
• Seo SR
• Park SW
• Kim DK

• KMID: 2371440
• DOI: http://doi.org/10.3346/jkms.2017.32.4.576

Abstract

The aim of this study was to assess the prevalence of Marfan syndrome (MFS) in Korean adults. Data were collected from the National Health Insurance Service in Korea from 2006 through 2013. The data consisted of primary diagnoses related to MFS (Q87.4) diagnosed according to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems. The age-standardized prevalence of MFS in adults was calculated using the estimated Korean population in 2010 as a reference. Overall, the prevalence of MFS was 0.90 per 100,000 persons in 2006 and 2.27 in 2013. For males in 2013, the prevalence per 100,000 persons was 2.61 in overall and 4.32 in 15-19 years-old. For females in 2013, the prevalence per 100,000 persons was 1.92 in overall and 3.02 in 10-14 years-old. In conclusion, currently, the age-standardized overall prevalence of MFS was 2.27 persons per 100,000 persons. And the overall age-standardized prevalence of MFS increased between 2006 and 2013 especially in 15-19 years-old males and 10-14 years-old females.

Keyword

Prevalence; Marfan Syndrome; Republic of Korea

Figure

• 

  Fig. 1 Age-adjusted cumulative prevalence of MFS per 100,000 persons by age group and years (2006–2013) overall, in female, and in male. MFS = Marfan syndrome.

Reference

1. Kainulainen K, Karttunen L, Puhakka L, Sakai L, Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet. 1994; 6:64–69.

2. Dietz HC, Loeys B, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005; 139C:4–9.

3. McKusick VA. The defect in Marfan syndrome. Nature. 1991; 352:279–281.

4. Robbins SL, Cotran RS, Kumar V. Pocket Companion to Pathologic Basis of Disease. Philadelphia, PA: W.B. Saunders Company;1991.

5. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006; 312:117–121.

6. Groth KA, Hove H, Kyhl K, Folkestad L, Gaustadnes M, Vejlstrup N, Stochholm K, Østergaard JR, Andersen NH, Gravholt CH. Prevalence, incidence, and age at diagnosis in Marfan syndrome. Orphanet J Rare Dis. 2015; 10:153.

7. Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008; 117:2802–2813.

8. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996; 62:417–426.

9. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010; 47:476–485.

10. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelpia, PA: Lippincott Williams & Winkins;2008.

11. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2006 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

12. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2007 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

13. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2008 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

14. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2009 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

15. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2010 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

16. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2011 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

17. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2012 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

18. National Health Insurance Service (KR). Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2013 [Internet]. accessed on 20 December 2016. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321.

19. Korean Statistical Information Service. Census [Internet]. accessed on 1 December 2016. Available at http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=A.

20. Jang SY, Ju EY, Seo SR, Choi JY, Park SJ, Kim DK, Park SW. Changes in the etiology of valvular heart disease in the rapidly aging Korean population. Int J Cardiol. 2014; 174:355–359.

21. Chiu HH, Wu MH, Chen HC, Kao FY, Huang SK. Epidemiological profile of Marfan syndrome in a general population: a national database study. Mayo Clin Proc. 2014; 89:34–42.

22. Kwun Y, Kim SJ, Lee J, Isojima T, Choi DS, Kim DK, Huh J, Kang IS, Chang M, Cho SY, et al. Disease-specific growth charts of Marfan syndrome patients in Korea. J Korean Med Sci. 2015; 30:911–916.

23. Korean Statistical Information Service. Specific equipments by type of medical care institutions [Internet]. accessed on 1 December 2016. Available at http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=D.

24. Lim AY, Song JS, Kim EK, Jang SY, Chung TY, Choi SH, Sung K, Huh J, Kang IS, Choe YH, et al. Clinical characteristics of Marfan syndrome in Korea. Korean Circ J. 2016; 46:841–845.

25. Yuan SM, Jing H. Marfan’s syndrome: an overview. Sao Paulo Med J. 2010; 128:360–366.